Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PFE

Pfizer Inc

Dec 13 • 04:00PM ET

25.58

Dollar change +0.21
Percentage change 0.83	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK JNJ ABBV BMY LLY GILD AMGN BIIB REGN VRTX

| Held by: VTI VOO SCHD SPY IVV VTV XLV VYM VHT IWD

Scroll to Statements

Index	S&P 500	P/E	34.39	EPS (ttm)	0.74	Insider Own	0.03%	Shs Outstand	5.67B	Perf Week	-0.58%
Market Cap	144.96B	Forward P/E	8.86	EPS next Y	2.89	Insider Trans	-0.24%	Shs Float	5.67B	Perf Month	-4.27%
Income	4.27B	PEG	6.74	EPS next Q	0.48	Inst Own	67.54%	Short Float	1.60%	Perf Quarter	-14.93%
Sales	60.11B	P/S	2.41	EPS this Y	58.03%	Inst Trans	0.28%	Short Ratio	2.29	Perf Half Y	-7.08%
Book/sh	16.29	P/B	1.57	EPS next Y	-0.74%	ROA	1.97%	Short Interest	90.38M	Perf Year	-4.05%
Cash/sh	1.76	P/C	14.57	EPS next 5Y	5.10%	ROE	4.52%	52W Range	24.48 - 31.54	Perf YTD	-11.15%
Dividend Est.	1.67 (6.51%)	P/FCF	17.62	EPS past 5Y	-27.43%	ROI	2.84%	52W High	-18.90%	Beta	0.62
Dividend TTM	1.68 (6.57%)	Quick Ratio	0.73	Sales past 5Y	10.96%	Gross Margin	58.50%	52W Low	4.49%	ATR (14)	0.55
Dividend Ex-Date	Nov 08, 2024	Current Ratio	1.00	EPS Y/Y TTM	-59.54%	Oper. Margin	16.32%	RSI (14)	43.95	Volatility	2.15% 2.30%
Employees	88000	Debt/Eq	0.73	Sales Y/Y TTM	-12.29%	Profit Margin	7.11%	Recom	2.23	Target Price	31.80
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	284.91%	Payout	439.41%	Rel Volume	0.73	Prev Close	25.37
Sales Surprise	18.63%	EPS Surprise	72.53%	Sales Q/Q	33.78%	Earnings	Oct 29 BMO	Avg Volume	39.41M	Price	25.58
SMA20	0.24%	SMA50	-6.03%	SMA200	-8.60%	Trades		Volume	28,943,423	Change	0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Today 12:20PM	Pfizer Raises Quarterly Dividend to $0.43, Offering 6.66% Yield (GuruFocus.com)
12:15PM	Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report (Benzinga)
09:59AM	Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell In December 2024? (Investor's Business Daily)
08:20AM	Pfizer announces results from PATINA trial (TipRanks)
07:55AM	SABCS: Pfizers IBRANCE combo improves PFS in breast cancer study (Clinical Trials Arena)
02:51AM	Loading…
02:51AM	Will the anti-woke movement derail DEI efforts in pharma? (Pharma Voice)
Dec-12-24 05:25PM	Pfizer Declares First-Quarter 2025 Dividend (Business Wire)
12:35PM	Pfizer's Cancer Drug Ibrance Combo Therapy Extends Median Progression-Free Survival By Over 15 Months In certain Of Breast Cancer Patients (Benzinga)
10:58AM	Pfizer and Amazon Explore Collaboration with RFK Jr. on Climate and Health Crisis (GuruFocus.com)
08:15AM	Pfizers IBRANCE in Combination with Standard-of-Care Therapies Extends Median Progression-Free Survival by Over 15 Months in Phase 3 PATINA Study in Patients with HR+, HER2+ Metastatic Breast Cancer (Business Wire)
03:00AM	How Pfizer management outplayed activist investor Starboard (Pharmaceutical Technology)
Dec-11-24 05:45PM	Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
12:23PM	Health execs reckon with patient outrage after UnitedHealthcare killing (Reuters)
12:23PM	Health care execs seek to better understand patient outrage after UnitedHealthcare killing (Reuters)
05:38AM	Arvinas and Pfizers combo therapy shows promise in breast cancer trial (Clinical Trials Arena)
11:39PM	Loading…
Dec-10-24 11:39PM	Is Pfizer Inc. (PFE) the Best American Dividend Stock to Buy Right Now? (Insider Monkey)
01:23PM	Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients (Benzinga)
10:33AM	RSV prophylactic market to reach $6.2bn in 8MM by 2030 (Pharmaceutical Technology)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of December 17 Conference Call with Analysts to Provide Full-Year 2025 Financial Guidance (Business Wire)
09:05AM	Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium (GlobeNewswire)
07:22AM	ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T (BioPharma Dive)
05:48AM	3 Magnificent S&P 500 Dividend Stock Down 35% to Buy and Hold Forever (Motley Fool)
Dec-09-24 09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-08-24 09:14PM	Apple Tops the List of Best-Managed Companies of 2024 (The Wall Street Journal)
09:00AM	Should You Buy the S&P 500's Highest-Yielding Dividend Stocks Heading Into 2025? (Motley Fool)
Dec-07-24 11:27AM	Want an Extra $1,000 of Dividend Income in 2025? Invest $11,400 in These 3 High-Yield Stocks. (Motley Fool)
05:30AM	Dividend Stocks Are Primed for a Comeback in 2025 (The Wall Street Journal)
Dec-06-24 03:22AM	Why Pfizer (PFE) Is Among the Best Affordable Stocks to Buy Right Now (Insider Monkey)
Dec-05-24 05:06PM	Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS (Business Wire)
07:15AM	Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? (Motley Fool)
04:55AM	Loading…
04:55AM	Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now. (Motley Fool)
Dec-04-24 01:12PM	Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS? (Investor's Business Daily)
Dec-03-24 01:52PM	Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments (Benzinga)
Dec-02-24 07:48AM	Analyst Report: Pfizer Inc. (Morningstar Research)
06:46AM	Hong Kong regulator accepts Everest's ulcerative colitis therapy NDA (Pharmaceutical Business Review)
04:33AM	3 Magnificent Dividend Stocks With Yields Above 6% to Buy in December (Motley Fool)
Dec-01-24 05:52AM	3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later (Motley Fool)
Nov-29-24 09:00AM	How Much Would It Take To Earn $100 A Month From Pfizer Stock? (Benzinga)
08:45AM	Is This a New Reason to Buy Pfizer Stock Hand Over Fist? (Motley Fool)
04:53AM	Black Friday Sale for Income Investors: These 3 Ultra-High-Yield Dividend Stocks Are Bargain Buys (Motley Fool)
Nov-28-24 11:31AM	Pfizer (PFE) Down 9.4% Since Last Earnings Report: Can It Rebound? (Zacks)
09:40AM	Are Investors Undervaluing Pfizer (PFE) Right Now? (Zacks)
06:17AM	Is Pfizer Stock in Trouble? (Motley Fool)
05:39AM	Why Pfizer Inc. (PFE) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)
Nov-27-24 05:31AM	Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead? (Motley Fool)
Nov-26-24 03:41PM	White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs (The Wall Street Journal)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:30AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500? (Motley Fool)
07:34AM	Amgen Obesity Drug Cut Weight In Closely Watched Study (The Wall Street Journal)
05:03AM	2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income (Motley Fool)
Nov-25-24 04:16PM	BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug (Investor's Business Daily)
11:31AM	Pfizer and Schlumberger are January Bounce Candidates (GuruFocus.com)
09:40AM	BridgeBio Soars After Drug Gets Nod in Rare Heart Condition (Bloomberg)
09:03AM	FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market (Benzinga)
08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Nov-23-24 07:20AM	3 Dividend Stocks That Are Screaming Buys in November (Motley Fool)
05:00AM	The Current 'Trump Trade' Is Less Euphoric And More Strategic (Investopedia)
Nov-22-24 04:17PM	RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried? (Investor's Business Daily)
02:16PM	BridgeBio heart drug approved by FDA, setting up battle with Pfizer (BioPharma Dive)
01:32PM	Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference (Investopedia)
08:00AM	Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry? (Investor's Business Daily)
06:36AM	Zai Lab and Pfizer to commercialise XACDURO in China (Pharmaceutical Technology)
12:01AM	The Irish Government Is Unbelievably Rich. Its Largely Thanks to Uncle Sam. (The Wall Street Journal)
Nov-21-24 08:15AM	2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist (Motley Fool)
04:30AM	EC marketing authorisation granted to Pfizers HYMPAVZI for haemophilia (Pharmaceutical Technology)
04:25AM	2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years (Motley Fool)
04:00AM	Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO (Sulbactam-Durlobactam) (Business Wire)
Nov-20-24 11:08AM	Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief (GuruFocus.com)
10:25AM	Pfizer plucks internal candidate to replace RandD head Dolsten, triggering series of leadership shakeups (FierceBiotech.com)
06:45AM	Pfizer Announces New Chief Scientific Officer and President, Research and Development (Business Wire)
06:45AM	Pfizer Announces New Chief Scientific Officer and President, Research & Development (Business Wire)
06:27AM	Pfizer names oncology head Chris Boshoff as R&D chief (Reuters)
06:15AM	Pfizer Names New R&D Chief (The Wall Street Journal)
06:12AM	Pfizer, under pressure to change, names oncology head as new R&D chief (BioPharma Dive)
05:48AM	Is It Time to Sell Eli Lilly and Pfizer Stocks? (Motley Fool)
04:00AM	European Commission Approves Pfizer's HYMPAVZI (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors (Business Wire)
Nov-19-24 05:05PM	Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules (Reuters)
02:44PM	BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market (Benzinga)
Nov-18-24 05:49PM	RFK Jr.'s HHS nomination sparks concern over pharma stocks (Yahoo Finance Video)
05:49PM	Jim Cramer on Pfizer Inc. (PFE): Still, Anything Good There, It Could Fly' (Insider Monkey)
01:27PM	How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health (Yahoo Finance)
09:46AM	Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
07:30AM	Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer (Newsfile)
06:45AM	2 High-Yield Dividend Stocks I Can't Stop Buying (Motley Fool)
05:23AM	FDA endorses speedy approval path for Regenxbio Duchenne gene therapy (BioPharma Dive)
12:45AM	Analyst Report: Pfizer Inc. (Morningstar Research)
Nov-16-24 09:00AM	The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue? (Yahoo Finance)
Nov-15-24 05:14PM	S&P 500 Gains and Losses Today: Palantir Stock Jumps as Listing Heads to Nasdaq (Investopedia)
04:19PM	Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
04:18PM	How analysts are reacting to RFK Jr. as Trump's HHS pick (Yahoo Finance Video)
04:11PM	These Stocks Moved the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More (Barrons.com)
02:24PM	These Stocks Are Moving the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More (Barrons.com)
12:36PM	Outlook for Healthcare Stocks Dims With Choice of Kennedy to Lead HHS (Barrons.com)
12:04PM	Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head (Investopedia)
12:04PM	Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
10:46AM	Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick (Yahoo Finance Video)
09:43AM	Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of. (Yahoo Finance)
09:40AM	Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
09:34AM	Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too (The Wall Street Journal)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM
Gottlieb Scott	Director	Dec 15 '23	Buy	26.47	3,000	79,401	9,000	Dec 19 09:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience